Angion Biomedica Corp. (ANGN): Odds are Looking Good after Recent Activity – Invest Chronicle

Angion Biomedica Corp. (ANGN): Odds are Looking Good after Recent Activity

Let’s start up with the current stock price of Angion Biomedica Corp. (ANGN), which is $2.02 to be very precise. The Stock rose vividly during the last session to $2.02 after opening rate of $1.45 while the lowest price it went was recorded $1.44 before closing at $1.54.Recently in News on May 16, 2022, Angion Provides Corporate Update and Reports First Quarter 2022 Financial Results. — Ended the quarter with $73M in cash and cash equivalents sufficient to fund operations well into 2023. You can read further details here

Angion Biomedica Corp. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.1200 on 01/04/22, with the lowest value was $1.0800 for the same time period, recorded on 05/18/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Angion Biomedica Corp. (ANGN) full year performance was -84.50%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Angion Biomedica Corp. shares are logging -87.02% during the 52-week period from high price, and 87.91% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.08 and $15.56.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 553896 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Angion Biomedica Corp. (ANGN) recorded performance in the market was -30.34%, having the revenues showcasing 2.54% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 56.94M, as it employees total of 39 workers.

Specialists analysis on Angion Biomedica Corp. (ANGN)

During the last month, 0 analysts gave the Angion Biomedica Corp. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 1.8400, with a change in the price was noted -0.15. In a similar fashion, Angion Biomedica Corp. posted a movement of -6.91% for the period of last 100 days, recording 102,630 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ANGN is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Trends and Technical analysis: Angion Biomedica Corp. (ANGN)

Raw Stochastic average of Angion Biomedica Corp. in the period of last 50 days is set at 84.38%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 100.00%. In the last 20 days, the company’s Stochastic %K was 55.42% and its Stochastic %D was recorded 36.66%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -30.34%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -22.90%, alongside a downfall of -84.50% for the period of the last 12 months. The shares increased approximately by 26.25% in the 7-day charts and went down by 57.81% in the period of the last 30 days. Common stock shares were driven by 2.54% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts